This Stock Has Run Up 173% Over 1 Year And Cathie Wood Is Booking Profit
Cathie Wood-led Ark Invest has been booking profit in Snap Inc (NYSE: SNAP) as shares of the social media company soar in the past year.
Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology
Scholar Rock (NASDAQ: SRRK) today announced an e-poster presentation of clinical results from the TOPAZ Phase 2 trial (NCT03921528) that evaluated apitegromab in patients with Type 2 and Type 3 spinal muscular atrophy (SMA) at the 25th World Congress of Neurology (WCN) taking place October 3-7, 2021.
Esports Technologies To Host Call On Monday, Oct. 4 At 4 p.m. EDT To Discuss Planned Acquisition Of Aspire’s Business-2-Consumer Unit
Esports Technologies, Inc. (NASDAQ:EBET), a leading global provider of advanced esports wagering products and technology, will host a conference call on Monday, October 4 at 4:00 pm Eastern, to discuss its
Shattuck Labs To Present Clinical Data On SL-172154 And SL-279252 And Preclinical Data On SL-9258 At 2021 Society For Immunotherapy Of Cancer (SITC) Annual Meeting
Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with
Ocuphire Pharma To Present Data On Phase 2b Trial For APX3330 For Retina At Ophthalmology Innovation Summit Retina@ASRS Innovation Company Showcase Oct. 7 At 10:16 a.m. EDT, Diabetic Symposium Oct. 9 9:51 a.m. EDT
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that its
Wrap Technologies To Present At Lytham Partners Fall Investor Conference On Oct. 5, 2021 2:20 p.m. EDT, LD Micro Main Event Oct. 12 3 p.m. EDT
2021 Lytham Partners Fall Investor Conference to be held on October 5th
LD Micro Main Event to be held on October 12th
TEMPE, Ariz., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (the “Company”
CRISPR Therapeutics To Present Preclinical Data At Society For Immunotherapy Of Cancer (SITC) 36th Annual Meeting On Nov. 10
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced two poster presentations at the Society for Immunotherapy of
ALX Oncology Announces 4 Abstracts Accepted For Presentation At Society For Immunotherapy Of Cancer 36th Annual Meeting On Nov. 10-14
ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company"), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced that four abstracts
Agenus To Present AGEN1181 Clinical Data At SITC On Nov. 10-14
Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections,
Tempest Announces Presentation At Society For Immunotherapy Of Cancer (SITC) 36th Annual Meeting On Nov. 10-14
Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today announced the acceptance of